1. Effect of Glucagon-Like Peptide-I (GLP- I) Analogue in Patients with Stable Coronary Artery Disease With Left Ventricular Ejection Fraction ≤ 40 %. Principal Investigator:…
Slide 1 Impact of enzymatic modification of whey proteins on their bioactive properties R.J. FitzGerald, A.B. Nongonierma and M.B. O’Keeffe Department of Life Sciences…
Slide 1 Effect of Glucagon-Like Peptide-I (GLP- I) Analogue in Patients with Stable Coronary Artery Disease With Left Ventricular Ejection Fraction ≤ 40 %. Principal Investigator:Wamiq…